Reference
Dyer O. US drug maker is challenged over decision to force patients to use new version of drug as patent expiry looms. BMJ 349: g5775, 22 Sep 2014. Available from: URL: http://dx.doi.org/10.1136/bmj.g5775
Rights and permissions
About this article
Cite this article
Actavis challenged over switch to Namenda XR. PharmacoEcon Outcomes News 712, 33 (2014). https://doi.org/10.1007/s40274-014-1578-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1578-4